TELETRADER News
8/12, 7:21 PM (Source: TeleTrader)
more TeleTrader news

J&J vaccine clinically effective against Delta strain - Fauci

Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases, stated during a briefing on Thursday that Johnson & Johnson COVID-19 vaccine is now clinically proven to be effective against the Delta strain, joining 5 other jabs with similar capability.

Research has revealed that the J&J vaccine provides durable antibody and cellular immune response against the Delta variant with "minimal decreases for at least 8 months" following inoculation.

According to the South African Sisonke study, 91-96% of vaccinated patients were protected from virus-caused fatalities, while 71% were able to avoid hospitalizations. Meanwhile, 96% of those, who had received the J&J shot and still contracted the virus had mild infection reaction.

Breaking the News / LH